CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
FID 114675A Multi-Purpose Disinfecting Solution (MPDS) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01341990
NCT01341990N/ACompleted
CompareCT.gov

Effect of SiH MPDS FID 114675A vs. a Marketed Multi-Purpose Solution on Lens Moisture

Alcon Research·interventional·Posted Apr 26, 2011·Updated Apr 13, 2012

In Brief

A clinical study evaluating FID 114675A Multi-Purpose Disinfecting Solution (MPDS), ReNu Fresh Lens Comfort Multi-Purpose Solution (MPS), and 1 other intervention for Contact Lens Moisture. Completed, enrolled 68 participants across 1 site.

Detailed Summary

The purpose of the study is to evaluate the effect of an investigational multi-purpose disinfecting solution (MPDS) compared to a marketed multi-purpose solution on the moisture of silicone hydrogel contact lenses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContact Lens Moisture
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 26, 2011
Enrollment StartNov 1, 2009
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.2 years ago

Interventions

FID 114675A Multi-Purpose Disinfecting Solution (MPDS)device

Investigational solution intended for use as a cleaning, rinsing, reconditioning, disinfecting, and storage solution for silicone hydrogel and soft contact lenses

ReNu Fresh Lens Comfort Multi-Purpose Solution (MPS)device

Commercially marketed prodouct indicated for cleaning, removing protein deposits, rinsing, disinfecting, and storing soft contact lenses

Silicone Hydrogel Contact Lensesdevice

Commercially marketed silicone hydrogel contact lenses per habitual prescription for daily wear use, at least 8 hours/day. New pair dispensed at Day 0 (Baseline Visit) and at the conclusion of Day 1 (Visit 2).